Cargando…
What Evidence Is There That Gadobutrol Causes Increasing Signal Intensity within the Dentate Nucleus and Globus Pallidus on Unenhanced T1W MRI in Patients with RRMS?
• The study by Stojanov et al does not convincingly support the conclusion that gadobutrol causes higher T1 enhancement in brain on unenhanced MRI • The study by Stojanov et al does not rule out confounding factors • The study by Stojanov et al has limitations in study design
Autores principales: | Agris, Jacob, Pietsch, Hubertus, Balzer, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750553/ https://www.ncbi.nlm.nih.gov/pubmed/26391362 http://dx.doi.org/10.1007/s00330-015-4019-2 |
Ejemplares similares
-
Safety of meglumine gadoterate (Gd-DOTA)-enhanced MRI compared to unenhanced MRI in patients with chronic kidney disease (RESCUE study)
por: Deray, Gilbert, et al.
Publicado: (2012) -
Penetration and distribution of gadolinium-based contrast agents into the cerebrospinal fluid in healthy rats: a potential pathway of entry into the brain tissue
por: Jost, Gregor, et al.
Publicado: (2016) -
Different Impact of Gadopentetate and Gadobutrol on Inflammation-Promoted Retention and Toxicity of Gadolinium Within the Mouse Brain
por: Anderhalten, Lina, et al.
Publicado: (2022) -
USPIO-enhanced MRI of pelvic lymph nodes at 7-T: preliminary experience
por: Philips, Bart W. J., et al.
Publicado: (2019) -
MRI of colorectal cancer liver metastases: comparison of orally administered manganese with intravenously administered gadobenate dimeglumine
por: Brismar, Torkel B., et al.
Publicado: (2011)